Luminate Accelerator Continues Support of Photonics Industry as Cohort-Five Application Period Nears a Close

Via Photonics Media

ROCHESTER, N.Y., Jan. 12, 2022 — As members of its first four cohorts continue to ascend the commercial optics and photonics landscape, the Rochester, N.Y.-based Luminate accelerator is less than one week away from the close of applications for finalists for its fifth cohort. The largest business accelerator for optics, photonics, and imaging (OPI) startups crowned its most recent winner in September, upon the completion of the six-month program that aims to speed the commercialization of finalists’ technologies and businesses.

Luminate is seeking applications for cohort 5 before 11:59 p.m. Monday, Jan. 17. Startups developing a new application that leverages some aspect of OPI are encouraged to apply. Previous finalists’ products have supported autonomous vehicles, augmented reality/virtual reality, climate tech, communications, defense, entertainment, medical devices, quantum computing, security, and more.

The accelerator welcomed its first cohort in 2018, with finalists from three countries representing the fields of spectroscopy and medical devices; photonic devices, lasers, materials, and display; and augmented and virtual reality, sensors, instrumentation, and image recognition. In subsequent cohorts, Luminate has received applications from companies in more than 20 countries.

The types of technologies that the accelerator has welcomed into its network reflect the key shifts and trends that are shaping the industry’s ecosystem. Many of the technologies that Luminate finalists have developed — from those aimed at everything from cybersecurity to photonic smart coatings for solar panels — have helped to inspire those trends.

“As the program has progressed, we have begun to see more deep tech, and integrated photonics companies. We are also seeing later stage companies specifically looking to scale their technology and business,” said Sujatha Ramanujan, Luminate’s managing director. “Prior cohorts tended to be more medical device focused. As the program’s reputation has grown, we are attracting companies seeking the specific assistance Rochester and its rich ecosystem of resources can provide.”

View Full Story